News
AWHL
0.395
+3.95%
0.015
Weekly Report: what happened at AWHL last week (0713-0717)?
Weekly Report · 1d ago
Aspira Women’s Health enters $1.05 million subordinated loan agreement with Agile Lending
PUBT · 5d ago
Aspira Women’s Health CFO John Strahley files initial beneficial ownership statement
PUBT · 5d ago
Weekly Report: what happened at AWHL last week (0706-0710)?
Weekly Report · 07/13 10:02
Weekly Report: what happened at AWHL last week (0629-0703)?
Weekly Report · 07/06 10:05
Weekly Report: what happened at AWHL last week (0622-0626)?
Weekly Report · 06/29 10:01
Aspira Women’s Health Announces CEO Leadership Transition
TipRanks · 06/22 13:51
Aspira Women’s Health names Chairman John Fraser interim CEO after Michael Buhle exits
PUBT · 06/22 13:13
Weekly Report: what happened at AWHL last week (0615-0619)?
Weekly Report · 06/22 10:08
Aspira Women’s Health Shareholders Approve Board and Incentive Plan
TipRanks · 06/17 20:49
Aspira Women’s Health shareholders approved amendment to 2019 stock incentive plan increasing share pool by 5 million
PUBT · 06/17 20:28
Weekly Report: what happened at AWHL last week (0608-0612)?
Weekly Report · 06/15 10:09
Major Insider Move Signals Growing Confidence in Aspira Women’s Health
TipRanks · 06/10 02:09
Aspira Women’s Health 10% owner Jack W. Schuler reports $0.45 share purchase worth $100,000
PUBT · 06/09 20:53
Aspira Women’s Health Completes Private Equity Financing
TipRanks · 06/09 12:21
Aspira Women’s Health prices private placement of 3,300,000 shares at $0.45 each
PUBT · 06/09 11:48
Weekly Report: what happened at AWHL last week (0601-0605)?
Weekly Report · 06/08 10:06
Weekly Report: what happened at AWHL last week (0525-0529)?
Weekly Report · 06/01 10:09
Aspira Women’s Health, Cleveland Clinic Launch Diagnostics Collaboration
TipRanks · 05/26 13:34
Weekly Report: what happened at AWHL last week (0518-0522)?
Weekly Report · 05/25 10:12
More
Webull provides a variety of real-time AWHL stock news. You can receive the latest news about Aspira Womens Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About AWHL
Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their initial clinical assessment indicates the mass is indeterminate or benign. The Ova1Plus is a reflex process of two tests, Ova1 and Overa, to assess the risk of ovarian malignancy in women with an adnexal mass planned for surgery. Its product pipelines are OVAinform and ENDOinform. OVAinform is a test that combines serum proteins, clinical data (metadata), and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass. ENDOinform is a test program that combines serum proteins, clinical data (metadata), and miRNA for the identification of endometriosis.